newsfilter
← Latest News
Business Wire·

Five Prime Therapeutics to Present at Upcoming Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immune modulators and precision therapies for solid tumor cancers, today announced that Helen Collins, M.D., Executive Vice President and Chief Medical Officer, is scheduled to present at the following investor conference: